Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Double-blind, Randomized, Placebo-controlled, Descending Age, Dose-escalation Study of the Safety, and Immunogenicity of the Trivalent P2-VP8 Subunit Rotavirus Vaccine in Healthy South African Adults, Toddlers and Infants

NCT02646891 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT02646891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02646891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Double-blind, Randomized, Placebo-controlled, Descending Age, Dose-escalation Study of the Safety, and Immunogenicity of the Trivalent P2-VP8 Subunit Rotavirus Vaccine in Healthy South African Adults, Toddlers and Infants
Lead sponsor
PATH
Phase
Phase 1/2
Overall status
Completed
Start date
February 15, 2016
Completion date
December 22, 2017
Enrollment
618 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

healthy